Cargando…

Early recurrence of myocarditis with atrioventricular block while wearing a wearable cardioverter-defibrillator after fulminant myocarditis: A case report

Detalles Bibliográficos
Autores principales:	Ikebe, Ryokan, Kikuchi, Noriko, Minami, Yuichiro, Yoshizawa, Saeko, Nagao, Michinobu, Yamaguchi, Junichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363458/ https://www.ncbi.nlm.nih.gov/pubmed/37492059 http://dx.doi.org/10.1016/j.hrcr.2023.04.019

Ejemplares similares

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2023)

Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
por: Israel, Carsten, et al.
Publicado: (2022)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Case Report: III° atrioventricular block due to fulminant myocarditis managed with non-invasive transcutaneous pacing
por: Devkota, Kiran, et al.
Publicado: (2018)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
por: Nakashima, Hiroshi, et al.
Publicado: (2013)

Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report
por: Onishi, Naoaki, et al.
Publicado: (2023)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Azd-1222: Fulminant myocarditis: case report
Publicado: (2022)

Fulminant Bacterial Myocarditis Presenting as Myocardial Infarction
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Fulminant myocarditis in adults: a narrative review
por: Montero, Santiago, et al.
Publicado: (2022)

Clinical and electrocardiographic characteristics in patients with fulminant myocarditis
por: Itoh, Tomonori, et al.
Publicado: (2022)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

COVID-19 fulminant myocarditis: a case report
por: Bernal-Torres, Wikler, et al.
Publicado: (2020)

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
por: Hu, Hongde, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2mreict0r6pr3oo7orosdmph6c